The DOI matches its Crossref record; 251 of the 251 references it cites were found in a registry or an index.
Clostridium difficile infection
Open accessAbstract
Infection of the colon with the Gram-positive bacterium Clostridium difficile is potentially life threatening, especially in elderly people and in patients who have dysbiosis of the gut microbiota following antimicrobial drug exposure. C. difficile is the leading cause of health-care-associated infective diarrhoea. The life cycle of C. difficile is influenced by antimicrobial agents, the host immune system, and the host microbiota and its associated metabolites. The primary mediators of inflammation in C. difficile infection (CDI) are large clostridial toxins, toxin A (TcdA) and toxin B (TcdB), and, in some bacterial strains, the binary toxin CDT. The toxins trigger a complex cascade of host cellular responses to cause diarrhoea, inflammation and tissue necrosis — the major symptoms of CDI. The factors responsible for the epidemic of some C. difficile strains are poorly understood. Recurrent infections are common and can be debilitating. Toxin detection for diagnosis is important for accurate epidemiological study, and for optimal management and prevention strategies. Infections are commonly treated with specific antimicrobial agents, but faecal microbiota transplants have shown promise for recurrent infections. Future biotherapies for C. difficile infections are likely to involve defined combinations of key gut microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Self-citationCohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pepin, J., & Wilcox, M. H. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/651706 · Cited by 2,942
Self-citationBurden of Clostridium difficile Infection in the United States
Lessa, F. C., Mu, Y., Bamberg, W. M., Beldavs, Z. G., Dumyati, G. K., Dunn, J. R., Farley, M. M., Holzbauer, S. M., Meek, J. I., Phipps, E. C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408913 · Cited by 2,641
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
Buffie, C. G., Bucci, V., Stein, R. R., McKenney, P. T., Ling, L., Gobourne, A., No, D., Liu, H., Kinnebrew, M., Viale, A., et al. (2015) · Nature · doi:10.1038/nature13828 · Cited by 1,872
Zimlichman, E., Henderson, D., Tamir, O., Franz, C., Song, P., Yamin, C. K., Keohane, C., Denham, C. R., & Bates, D. W. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.9763 · Cited by 1,847
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections
Surawicz, C. M., Brandt, L. J., Binion, D. G., Ananthakrishnan, A. N., Curry, S. R., Gilligan, P. H., McFarland, L. V., Mellow, M., & Zuckerbraun, B. S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.4 · Cited by 1,645
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Louie, T. J., Miller, M. A., Mullane, K. M., Weiss, K., Lentnek, A., Golan, Y., Gorbach, S., Sears, P., & Shue, Y.-K. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0910812 · Cited by 1,585
Clostridium difficile Infection
Leffler, D. A., & Lamont, J. T. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1403772 · Cited by 1,450
Warny, M., Pepin, J., Fang, A., Killgore, G., Thompson, A., Brazier, J., Frost, E., & McDonald, L. C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67420-x · Cited by 1,430
Anti-virulence strategies to combat bacteria-mediated disease
Rasko, D. A., & Sperandio, V. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3013 · Cited by 1,373
Debast, S. B., Bauer, M. P., & Kuijper, E. J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12418 · Cited by 1,215
Self-citationGlucosylation of Rho proteins by Clostridium difficile toxin B
Just, I., Selzer, J., Wilm, M., Eichel-Streiber, C. V., Mann, M., & Aktories, K. (1995) · Nature · doi:10.1038/375500a0 · Cited by 1,032
Clostridium difficile infection in Europe: a hospital-based survey
Bauer, M. P., Notermans, D. W., van Benthem, B. H., Brazier, J. S., Wilcox, M. H., Rupnik, M., Monnet, D. L., van Dissel, J. T., & Kuijper, E. J. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61266-4 · Cited by 1,020
Self-citationAsymptomatic Carriage of Clostridium difficile and Serum Levels of IgG Antibody against Toxin A
Kyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420604 · Cited by 935
The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome
Sebaihia, M., Wren, B. W., Mullany, P., Fairweather, N. F., Minton, N., Stabler, R., Thomson, N. R., Roberts, A. P., Cerdeño-Tárraga, A. M., Wang, H., et al. (2006) · Nature Genetics · doi:10.1038/ng1830 · Cited by 879
The role of toxin A and toxin B in Clostridium difficile infection
Kuehne, S. A., Cartman, S. T., Heap, J. T., Kelly, M. L., Cockayne, A., & Minton, N. P. (2010) · Nature · doi:10.1038/nature09397 · Cited by 855
Emergence of Clostridium difficile-associated disease in North America and Europe
Kuijper, E. J., Coignard, B., & Tüll, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01580.x · Cited by 855
Self-citationThe Changing Epidemiology of Clostridium difficile Infections
Freeman, J., Bauer, M. P., Baines, S. D., Corver, J., Fawley, W. N., Goorhuis, B., Kuijper, E. J., & Wilcox, M. H. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00082-09 · Cited by 826
Self-citationHost and Pathogen Factors for Clostridium difficile Infection and Colonization
Loo, V. G., Bourgault, A.-M., Poirier, L., Lamothe, F., Michaud, S., Turgeon, N., Toye, B., Beaudoin, A., Frost, E. H., Gilca, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012413 · Cited by 797
HALL, I. C. (1935) · American Journal of Diseases of Children · doi:10.1001/archpedi.1935.01970020105010 · Cited by 772
Cornely, O. A., Crook, D. W., Esposito, R., Poirier, A., Somero, M. S., Weiss, K., Sears, P., & Gorbach, S. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70374-7 · Cited by 761
Treatment with Monoclonal Antibodies against Clostridium difficile Toxins
Lowy, I., Molrine, D. C., Leav, B. A., Blair, B. M., Baxter, R., Gerding, D. N., Nichol, G., Thomas, W. D., Leney, M., Sloan, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907635 · Cited by 746
Toxin B is essential for virulence of Clostridium difficile
Lyras, D., O’Connor, J. R., Howarth, P. M., Sambol, S. P., Carter, G. P., Phumoonna, T., Poon, R., Adams, V., Vedantam, G., Johnson, S., et al. (2009) · Nature · doi:10.1038/nature07822 · Cited by 745
Self-citationProbiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Goldenberg, J. Z., Ma, S. S., Saxton, J. D., Martzen, M. R., Vandvik, P. O., Thorlund, K., Guyatt, G. H., & Johnston, B. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006095.pub3 · Cited by 741
Emergence and global spread of epidemic healthcare-associated Clostridium difficile
He, M., Miyajima, F., Roberts, P., Ellison, L., Pickard, D. J., Martin, M. J., Connor, T. R., Harris, S. R., Fairley, D., Bamford, K. B., et al. (2013) · Nature Genetics · doi:10.1038/ng.2478 · Cited by 735
Self-citationPetrof, E. O., Gloor, G. B., Vanner, S. J., Weese, S. J., Carter, D., Daigneault, M. C., Brown, E. M., Schroeter, K., & Allen-Vercoe, E. (2013) · Microbiome · doi:10.1186/2049-2618-1-3 · Cited by 731
Bile Salts and Glycine as Cogerminants for Clostridium difficile Spores
Sorg, J. A., & Sonenshein, A. L. (2008) · Journal of Bacteriology · doi:10.1128/jb.01765-07 · Cited by 711
Dancer, S. J. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00020-14 · Cited by 679
Diverse Sources of C. difficile Infection Identified on Whole-Genome Sequencing
Eyre, D. W., Cule, M. L., Wilson, D. J., Griffiths, D., Vaughan, A., O'Connor, L., Ip, C. L. C., Golubchik, T., Batty, E. M., Finney, J. M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1216064 · Cited by 648
Self-citationGoorhuis, A., Bakker, D., Corver, J., Debast, S. B., Harmanus, C., Notermans, D. W., Bergwerff, A. A., Dekker, F. W., & Kuijper, E. J. (2008) · Clinical Infectious Diseases · doi:10.1086/592257 · Cited by 637
Self-citationYoungster, I., Russell, G. H., Pindar, C., Ziv-Baran, T., Sauk, J., & Hohmann, E. L. (2014) · JAMA · doi:10.1001/jama.2014.13875 · Cited by 629
Crobach, M. J. T., Planche, T., Eckert, C., Barbut, F., Terveer, E. M., Dekkers, O. M., Wilcox, M. H., & Kuijper, E. J. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.03.010 · Cited by 596
Self-citationOverdiagnosis of Clostridium difficile Infection in the Molecular Test Era
Polage, C. R., Gyorke, C. E., Kennedy, M. A., Leslie, J. L., Chin, D. L., Wang, S., Nguyen, H. H., Huang, B., Tang, Y.-W., Lee, L. W., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.4114 · Cited by 593
Battistuzzi, F. U., Feijao, A., & Hedges, S. B. (2004) · BMC Evolutionary Biology · doi:10.1186/1471-2148-4-44 · Cited by 588
Risk of Clostridium difficile Infection With Acid Suppressing Drugs and Antibiotics: Meta-Analysis
Kwok, C. S., Arthur, A. K., Anibueze, C. I., Singh, S., Cavallazzi, R., & Loke, Y. K. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.108 · Cited by 581
Slimings, C., & Riley, T. V. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt477 · Cited by 581
Yutin, N., & Galperin, M. Y. (2013) · Environmental Microbiology · doi:10.1111/1462-2920.12173 · Cited by 569
Riggs, M. M., Sethi, A. K., Zabarsky, T. F., Eckstein, E. C., Jump, R. L. P., & Donskey, C. J. (2007) · Clinical Infectious Diseases · doi:10.1086/521854 · Cited by 550
Lawley, T. D., Clare, S., Walker, A. W., Stares, M. D., Connor, T. R., Raisen, C., Goulding, D., Rad, R., Schreiber, F., Brandt, C., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002995 · Cited by 540
Bergström, A., Skov, T. H., Bahl, M. I., Roager, H. M., Christensen, L. B., Ejlerskov, K. T., Mølgaard, C., Michaelsen, K. F., & Licht, T. R. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.00342-14 · Cited by 532
Rea, M. C., Sit, C. S., Clayton, E., O'Connor, P. M., Whittal, R. M., Zheng, J., Vederas, J. C., Ross, R. P., & Hill, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913554107 · Cited by 530
Clinical Recognition and Diagnosis of Clostridium difficile Infection
Bartlett, J. G., & Gerding, D. N. (2008) · Clinical Infectious Diseases · doi:10.1086/521863 · Cited by 527
Johnson, S., Louie, T. J., Gerding, D. N., Cornely, O. A., Chasan-Taber, S., Fitts, D., Gelone, S. P., Broom, C., Davidson, D. M., & for the Polymer Alternative for CDI Treatment (PACT) investigators (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu313 · Cited by 527
Theriot, C. M., Bowman, A. A., & Young, V. B. (2016) · mSphere · doi:10.1128/msphere.00045-15 · Cited by 481
The Enterotoxin from Clostridium difficile (ToxA) Monoglucosylates the Rho Proteins
Just, I., Wilm, M., Selzer, J., Rex, G., von Eichel-Streiber, C., Mann, M., & Aktories, K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13932 · Cited by 478
Clabots, C. R., Johnson, S., Olson, M. M., Peterson, L. R., & Gerding, D. N. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/166.3.561 · Cited by 476
HOPKINS, M. J., & MACFARLANE, G. T. (2002) · Journal of Medical Microbiology · doi:10.1099/0022-1317-51-5-448 · Cited by 472
Planche, T. D., Davies, K. A., Coen, P. G., Finney, J. M., Monahan, I. M., Morris, K. A., O'Connor, L., Oakley, S. J., Pope, C. F., Wren, M. W., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70200-7 · Cited by 435
Self-citationClostridium difficile spore biology: sporulation, germination, and spore structural proteins
Paredes-Sabja, D., Shen, A., & Sorg, J. A. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.04.003 · Cited by 419
Clostridium difficile binary toxin CDT: Mechanism, epidemiology, and potential clinical importance
Gerding, D. N., Johnson, S., Rupnik, M., & Aktories, K. (2014) · Gut Microbes · doi:10.4161/gmic.26854 · Cited by 416
Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin
Cornely, O. A., Miller, M. A., Louie, T. J., Crook, D. W., & Gorbach, S. L. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis462 · Cited by 401
Effects of Clostridium difficile toxins given intragastrically to animals
Lyerly, D. M., Saum, K. E., MacDonald, D. K., & Wilkins, T. D. (1985) · Infection and Immunity · doi:10.1128/iai.47.2.349-352.1985 · Cited by 400
Can we identify patients at high risk of recurrent Clostridium difficile infection?
Kelly, C. P. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12046 · Cited by 396
Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea
Shim, J. K., Johnson, S., Samore, M. H., Bliss, D. Z., & Gerding, D. N. (1998) · The Lancet · doi:10.1016/s0140-6736(97)08062-8 · Cited by 391
A case-control study of community-associated Clostridium difficile infection
Wilcox, M. H., Mooney, L., Bendall, R., Settle, C. D., & Fawley, W. N. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn163 · Cited by 372
Self-citationThe Clostridium difficile spo0A Gene Is a Persistence and Transmission Factor
Deakin, L. J., Clare, S., Fagan, R. P., Dawson, L. F., Pickard, D. J., West, M. R., Wren, B. W., Fairweather, N. F., Dougan, G., & Lawley, T. D. (2012) · Infection and Immunity · doi:10.1128/iai.00147-12 · Cited by 360
Samore, M. H., Venkataraman, L., DeGirolami, P. C., Arbeit, R. D., & Karchmer, A. W. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)90008-x · Cited by 350
Davies, K. A., Longshaw, C. M., Davis, G. L., Bouza, E., Barbut, F., Barna, Z., Delmée, M., Fitzpatrick, F., Ivanova, K., Kuijper, E., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70991-0 · Cited by 343
Self-citationGerding, D. N., Meyer, T., Lee, C., Cohen, S. H., Murthy, U. K., Poirier, A., Van Schooneveld, T. C., Pardi, D. S., Ramos, A., Barron, M. A., et al. (2015) · JAMA · doi:10.1001/jama.2015.3725 · Cited by 342
Neal, M. D., Alverdy, J. C., Hall, D. E., Simmons, R. L., & Zuckerbraun, B. S. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e31822ade48 · Cited by 341
Riegler, M., Sedivy, R., Pothoulakis, C., Hamilton, G., Zacherl, J., Bischof, G., Cosentini, E., Feil, W., Schiessel, R., & LaMont, J. T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117885 · Cited by 340
Definition of the single integration site of the pathogenicity locus in Clostridium difficile
Braun, V., Hundsberger, T., Leukel, P., Sauerborn, M., & von Eichel-Streiber, C. (1996) · Gene · doi:10.1016/s0378-1119(96)00398-8 · Cited by 330
Eastwood, K., Else, P., Charlett, A., & Wilcox, M. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01082-09 · Cited by 330
Self-citationCarter, G. P., Chakravorty, A., Pham Nguyen, T. A., Mileto, S., Schreiber, F., Li, L., Howarth, P., Clare, S., Cunningham, B., Sambol, S. P., et al. (2015) · mBio · doi:10.1128/mbio.00551-15 · Cited by 324
Self-citationKhanna, S., Pardi, D. S., Kelly, C. R., Kraft, C. S., Dhere, T., Henn, M. R., Lombardo, M.-J., Vulic, M., Ohsumi, T., Winkler, J., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv766 · Cited by 321
Clostridium difficile infection: epidemiology, diagnosis and understanding transmission
Martin, J. S. H., Monaghan, T. M., & Wilcox, M. H. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.25 · Cited by 319
Self-citationInfection control measures to limit the spread of Clostridium difficile
Vonberg, R.-P., Kuijper, E. J., Wilcox, M. H., Barbut, F., Tüll, P., Gastmeier, P., van den Broek, P. J., Colville, A., Coignard, B., Daha, T., et al. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01992.x · Cited by 314
Self-citationLouie, T. J., Cannon, K., Byrne, B., Emery, J., Ward, L., Eyben, M., & Krulicki, W. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis338 · Cited by 310
Bartlett, J. G. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.supplement_4.s265 · Cited by 309
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile
Theriot, C. M., & Young, V. B. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104115 · Cited by 302
Abt, M. C., Lewis, B. B., Caballero, S., Xiong, H., Carter, R. A., Sušac, B., Ling, L., Leiner, I., & Pamer, E. G. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.06.011 · Cited by 294
Clostridium difficile infection in the community: a zoonotic disease?
Hensgens, M. P. M., Keessen, E. C., Squire, M. M., Riley, T. V., Koene, M. G. J., de Boer, E., Lipman, L. J. A., & Kuijper, E. J. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03853.x · Cited by 290
Self-citationRegulated transcription of Clostridium difficile toxin genes
Dupuy, B., & Sonenshein, A. L. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00663.x · Cited by 289
Economic healthcare costs of Clostridium difficile infection: a systematic review
Ghantoji, S. S., Sail, K., Lairson, D. R., DuPont, H. L., & Garey, K. W. (2010) · Journal of Hospital Infection · doi:10.1016/j.jhin.2009.10.016 · Cited by 288
Role of FliC and FliD Flagellar Proteins of Clostridium difficile in Adherence and Gut Colonization
Tasteyre, A., Barc, M.-C., Collignon, A., Boureau, H., & Karjalainen, T. (2001) · Infection and Immunity · doi:10.1128/iai.69.12.7937-7940.2001 · Cited by 286
Perelle, S., Gibert, M., Bourlioux, P., Corthier, G., & Popoff, M. R. (1997) · Infection and Immunity · doi:10.1128/iai.65.4.1402-1407.1997 · Cited by 283
Wiegand, P. N., Nathwani, D., Wilcox, M. H., Stephens, J., Shelbaya, A., & Haider, S. (2012) · Journal of Hospital Infection · doi:10.1016/j.jhin.2012.02.004 · Cited by 280
Self-citationFreeman, J., Vernon, J., Morris, K., Nicholson, S., Todhunter, S., Longshaw, C., & Wilcox, M. H. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.09.017 · Cited by 279
Self-citationMerrigan, M., Venugopal, A., Mallozzi, M., Roxas, B., Viswanathan, V. K., Johnson, S., Gerding, D. N., & Vedantam, G. (2010) · Journal of Bacteriology · doi:10.1128/jb.00445-10 · Cited by 271
Feazel, L. M., Malhotra, A., Perencevich, E. N., Kaboli, P., Diekema, D. J., & Schweizer, M. L. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku046 · Cited by 269
Clostridium difficile Infection in Infants and Children
COMMITTEE ON INFECTIOUS DISEASES, Schutze, G. E., Willoughby, R. E., Brady, M. T., Byington, C. L., Davies, H. D., Edwards, K. M., Glode, M. P., Jackson, M. A., Keyserling, H. L., et al. (2013) · PEDIATRICS · doi:10.1542/peds.2012-2992 · Cited by 256
Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor
Mani, N., & Dupuy, B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101126598 · Cited by 252
Financial burden of hospital-acquired Clostridium difficile infection
Wilcox, M. H., Cunniffe, J. G., Trundle, C., & Redpath, C. (1996) · Journal of Hospital Infection · doi:10.1016/s0195-6701(96)90122-x · Cited by 244
Self-citationStrategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: 2014 Update
Dubberke, E. R., Carling, P., Carrico, R., Donskey, C. J., Loo, V. G., McDonald, L. C., Maragakis, L. L., Sandora, T. J., Weber, D. J., Yokoe, D. S., et al. (2014) · Infection Control & Hospital Epidemiology · doi:10.1086/676023 · Cited by 240
Knetsch, C. W., Connor, T. R., Mutreja, A., van Dorp, S. M., Sanders, I. M., Browne, H. P., Harris, D., Lipman, L., Keessen, E. C., Corver, J., et al. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.45.20954 · Cited by 236
Self-citationZacharioudakis, I. M., Zervou, F. N., Pliakos, E. E., Ziakas, P. D., & Mylonakis, E. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.22 · Cited by 230
Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine
Savidge, T. C., Pan, W.-H., Newman, P., O’Brien, M., Anton, P. M., & Pothoulakis, C. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00902-8 · Cited by 230
Curry, S. R., Muto, C. A., Schlackman, J. L., Pasculle, A. W., Shutt, K. A., Marsh, J. W., & Harrison, L. H. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit475 · Cited by 228
Importance of Toxin A, Toxin B, and CDT in Virulence of an Epidemic Clostridium difficile Strain
Kuehne, S. A., Collery, M. M., Kelly, M. L., Cartman, S. T., Cockayne, A., & Minton, N. P. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit426 · Cited by 221
McDonald, E. G., Milligan, J., Frenette, C., & Lee, T. C. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.42 · Cited by 216
Fawley, W. N., Knetsch, C. W., MacCannell, D. R., Harmanus, C., Du, T., Mulvey, M. R., Paulick, A., Anderson, L., Kuijper, E. J., & Wilcox, M. H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118150 · Cited by 215
Self-citationSpina, A., Kerr, K. G., Cormican, M., Barbut, F., Eigentler, A., Zerva, L., Tassios, P., Popescu, G. A., Rafila, A., Eerola, E., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.04.007 · Cited by 209
Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread
Clements, A. C., Magalhães, R. J. S., Tatem, A. J., Paterson, D. L., & Riley, T. V. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70080-3 · Cited by 206
Differential effects of Clostridium difficile toxins A and B on rabbit ileum
Triadafilopoulos, G., Pothoulakis, C., O'Brien, M. J., & LaMont, J. T. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)91014-6 · Cited by 204
Global transcriptional control by glucose and carbon regulator CcpA in Clostridium difficile
Antunes, A., Camiade, E., Monot, M., Courtois, E., Barbut, F., Sernova, N. V., Rodionov, D. A., Martin-Verstraete, I., & Dupuy, B. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks864 · Cited by 204
A Role for TLR4 in Clostridium difficile Infection and the Recognition of Surface Layer Proteins
Ryan, A., Lynch, M., Smith, S. M., Amu, S., Nel, H. J., McCoy, C. E., Dowling, J. K., Draper, E., O'Reilly, V., McCarthy, C., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002076 · Cited by 198
Egerer, M., Giesemann, T., Jank, T., Satchell, K. J. F., & Aktories, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703062200 · Cited by 194
Toxin A-negative, toxin B-positive Clostridium difficile
Drudy, D., Fanning, S., & Kyne, L. (2007) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2006.04.003 · Cited by 192
Cyclic Diguanylate Inversely Regulates Motility and Aggregation in Clostridium difficile
Purcell, E. B., McKee, R. W., McBride, S. M., Waters, C. M., & Tamayo, R. (2012) · Journal of Bacteriology · doi:10.1128/jb.00100-12 · Cited by 191
Papatheodorou, P., Carette, J. E., Bell, G. W., Schwan, C., Guttenberg, G., Brummelkamp, T. R., & Aktories, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109772108 · Cited by 190
Toward a structural understanding of Clostridium difficile toxins A and B
Pruitt, R. N., & Lacy, D. B. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00028 · Cited by 187
Self-citationSecretion of Clostridium difficile Toxins A and B Requires the Holin-like Protein TcdE
Govind, R., & Dupuy, B. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002727 · Cited by 186
Hasegawa, M., Yamazaki, T., Kamada, N., Tawaratsumida, K., Kim, Y.-G., Núñez, G., & Inohara, N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003761 · Cited by 186
Multidrug resistance in European Clostridium difficile clinical isolates
Spigaglia, P., Barbanti, F., Mastrantonio, P., on behalf of the European Study Group on Clostridium difficile (ESGCD), Ackermann, G., Balmelli, C., Barbut, F., Bouza, E., Brazier, J., Delmee, M., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr292 · Cited by 183
Self-citationIntegration of Metabolism and Virulence by Clostridium difficile CodY
Dineen, S. S., McBride, S. M., & Sonenshein, A. L. (2010) · Journal of Bacteriology · doi:10.1128/jb.00341-10 · Cited by 181
Horizontal gene transfer converts non-toxigenic Clostridium difficile strains into toxin producers
Brouwer, M. S. M., Roberts, A. P., Hussain, H., Williams, R. J., Allan, E., & Mullany, P. (2013) · Nature Communications · doi:10.1038/ncomms3601 · Cited by 181
Yuan, P., Zhang, H., Cai, C., Zhu, S., Zhou, Y., Yang, X., He, R., Li, C., Guo, S., Li, S., et al. (2015) · Cell Research · doi:10.1038/cr.2014.169 · Cited by 179
The Morbidity, Mortality, and Costs Associated with Clostridium difficile Infection
Kwon, J. H., Olsen, M. A., & Dubberke, E. R. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2014.11.003 · Cited by 178
LaFrance, M. E., Farrow, M. A., Chandrasekaran, R., Sheng, J., Rubin, D. H., & Lacy, D. B. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500791112 · Cited by 175
Self-citationCarter, G. P., Lyras, D., Allen, D. L., Mackin, K. E., Howarth, P. M., O’Connor, J. R., & Rood, J. I. (2007) · Journal of Bacteriology · doi:10.1128/jb.00731-07 · Cited by 171
Self-citationClostridium difficile Toxins: Mediators of Inflammation
Shen, A. (2012) · Journal of Innate Immunity · doi:10.1159/000332946 · Cited by 171
The dlt operon confers resistance to cationic antimicrobial peptides in Clostridium difficile
McBride, S. M., & Sonenshein, A. L. (2011) · Microbiology · doi:10.1099/mic.0.045997-0 · Cited by 168
Clostridium difficile: New Insights into the Evolution of the Pathogenicity Locus
Monot, M., Eckert, C., Lemire, A., Hamiot, A., Dubois, T., Tessier, C., Dumoulard, B., Hamel, B., Petit, A., Lalande, V., et al. (2015) · Scientific Reports · doi:10.1038/srep15023 · Cited by 167
Clostridial Glucosylating Toxins Enter Cells via Clathrin-Mediated Endocytosis
Papatheodorou, P., Zamboglou, C., Genisyuerek, S., Guttenberg, G., & Aktories, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010673 · Cited by 160
Gonçalves, C., Decré, D., Barbut, F., Burghoffer, B., & Petit, J. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.5.1933-1939.2004 · Cited by 157
Clostridium difficilevirulence factors: Insights into an anaerobic spore-forming pathogen
Awad, M. M., Johanesen, P., Carter, G. P., Rose, E., & Lyras, D. (2014) · Gut Microbes · doi:10.4161/19490976.2014.969632 · Cited by 157
Self-citationMerrigan, M. M., Venugopal, A. A., Roxas, J. L., Anwar, F., Mallozzi, M., Roxas, B. P., Gerding, D. N., Viswanathan, V. K., & Vedantam, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078404 · Cited by 156
Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon.
Mitchell, T. J., Ketley, J. M., Haslam, S. C., Stephen, J., Burdon, D. W., Candy, D. C. A., & Daniel, R. (1986) · Gut · doi:10.1136/gut.27.1.78 · Cited by 155
Evidence for holin function of tcdE gene in the pathogenicity of Clostridium difficile
Tan, K. S., Wee, B. Y., & Song, K. P. (2001) · Journal of Medical Microbiology · doi:10.1099/0022-1317-50-7-613 · Cited by 153
Burden of Clostridium difficile Infection in the United States
Lessa, F. C., Winston, L. G., & McDonald, L. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1505190 · Cited by 152
Tleyjeh, I. M., Abdulhak, A. A. B., Riaz, M. A., Alasmari, F. A., Garbati, M. A., Alghamdi, M. A. A., Khan, A. R., Al-Tannir, M. A., Erwin, P. J., Ibrahim, T., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050836 · Cited by 151
Eckert, C., Emirian, A., Monnier, A. L., Cathala, L., de Montclos, H., Goret, J., Berger, P., Petit, A., de Chevigny, A., Jean‐Pierre, H., et al. (2014) · New Microbes and New Infections · doi:10.1016/j.nmni.2014.10.003 · Cited by 148
Clostridium difficile: isolation and characteristics (Plate VIII)
HAFIZ, S., & Oakley, C. L. (1976) · Journal of Medical Microbiology · doi:10.1099/00222615-9-2-129 · Cited by 146
Reveles, K. R., Lee, G. C., Boyd, N. K., & Frei, C. R. (2014) · American Journal of Infection Control · doi:10.1016/j.ajic.2014.06.011 · Cited by 145
Pettit, L. J., Browne, H. P., Yu, L., Smits, W. K., Fagan, R. P., Barquist, L., Martin, M. J., Goulding, D., Duncan, S. H., Flint, H. J., et al. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-160 · Cited by 143
Self-citationMani, N., Lyras, D., Barroso, L. A., Howarth, P. M., Wilkins, T. D., Rood, J. I., Sonenshein, A. L., & Dupuy, B. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.21.5971-5978.2002 · Cited by 142
Self-citationThe toxigenic element of Clostridium difficile strain VPI 10463
Hammond, G. A., & Johnson, J. L. (1995) · Microbial Pathogenesis · doi:10.1016/s0882-4010(95)90263-5 · Cited by 141
Clostridium difficile toxin synthesis is negatively regulated by TcdC
Dupuy, B., Govind, R., Antunes, A., & Matamouros, S. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47775-0 · Cited by 140
Lim, S. K., Stuart, R. L., Mackin, K. E., Carter, G. P., Kotsanas, D., Francis, M. J., Easton, M., Dimovski, K., Elliott, B., Riley, T. V., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu203 · Cited by 140
Self-citationClostridium difficile phages: still difficult?
Hargreaves, K. R., & Clokie, M. R. J. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00184 · Cited by 139
Diverse mechanisms regulate sporulation sigma factor activity in the Firmicutes
Fimlaid, K. A., & Shen, A. (2015) · Current Opinion in Microbiology · doi:10.1016/j.mib.2015.01.006 · Cited by 139
A small-molecule antivirulence agent for treating Clostridium difficile infection
Bender, K. O., Garland, M., Ferreyra, J. A., Hryckowian, A. J., Child, M. A., Puri, A. W., Solow-Cordero, D. E., Higginbottom, S. K., Segal, E., Banaei, N., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac9103 · Cited by 136
Models for the study of Clostridium difficile infection
Best, E. L., Freeman, J., & Wilcox, M. H. (2012) · Gut Microbes · doi:10.4161/gmic.19526 · Cited by 135
Self-citationKarlsson, S., Lindberg, A., Norin, E. L., BURMAN, L. G., & Åkerlund, T. (2000) · Infection and Immunity · doi:10.1128/iai.68.10.5881-5888.2000 · Cited by 135
Integration of metabolism and virulence in Clostridium difficile
Bouillaut, L., Dubois, T., Sonenshein, A. L., & Dupuy, B. (2014) · Research in Microbiology · doi:10.1016/j.resmic.2014.10.002 · Cited by 132
Janoir, C., Péchiné, S., Grosdidier, C., & Collignon, A. (2007) · Journal of Bacteriology · doi:10.1128/jb.00578-07 · Cited by 131
Mechanism ofClostridium difficileToxin A–Induced Apoptosis in T84 Cells
Brito, G. A. D. C., Fujji, J., Carneiro‐Filho, B. A., Lima, A. Â. M., Obrig, T. G., & Guerrant, R. L. (2002) · The Journal of Infectious Diseases · doi:10.1086/344729 · Cited by 130
Human α-Defensins Inhibit Clostridium difficile Toxin B
Giesemann, T., Guttenberg, G., & Aktories, K. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.008 · Cited by 129
Farrow, M. A., Chumbler, N. M., Lapierre, L. A., Franklin, J. L., Rutherford, S. A., Goldenring, J. R., & Lacy, D. B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313658110 · Cited by 128
Self-citationKnetsch, C. W., Lawley, T. D., Hensgens, M. P. M., Corver, J., Wilcox, M., & Kuijper, E. J. (2013) · Eurosurveillance · doi:10.2807/ese.18.04.20381-en · Cited by 128
Self-citationGebhart, D., Lok, S., Clare, S., Tomas, M., Stares, M., Scholl, D., Donskey, C. J., Lawley, T. D., & Govoni, G. R. (2015) · mBio · doi:10.1128/mbio.02368-14 · Cited by 127
Meouche, I. E., Johann, P., Monot, M., Soutourina, O. A., Pestel‐Caron, M., Dupuy, B., & Pons, J.-L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083748 · Cited by 126
Costs of nosocomial Clostridium difficile-associated diarrhoea
Vonberg, R., Reichardt, C., Behnke, M., Schwab, F., Zindler, S., & Gastmeier, P. (2008) · Journal of Hospital Infection · doi:10.1016/j.jhin.2008.05.004 · Cited by 126
McKee, R. W., Mangalea, M. R., Purcell, E. B., Borchardt, E. K., & Tamayo, R. (2013) · Journal of Bacteriology · doi:10.1128/jb.00501-13 · Cited by 125
Tickler, I. A., Goering, R. V., Whitmore, J. D., Lynn, A. N. W., Persing, D. H., & Tenover, F. C. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02775-13 · Cited by 123
Smith, S. M. E., Min, J., Ganesh, T., Diebold, B. A., Kawahara, T., Zhu, Y., McCoy, J. W., Sun, A., Snyder, J. P., Fu, H., et al. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.04.015 · Cited by 120
The agr Locus Regulates Virulence and Colonization Genes in Clostridium difficile 027
Martin, M. J., Clare, S., Goulding, D., Faulds‐Pain, A., Barquist, L., Browne, H. P., Pettit, L. J., Dougan, G., Lawley, T. D., & Wren, B. W. (2013) · Journal of Bacteriology · doi:10.1128/jb.00473-13 · Cited by 113
Toxin Synthesis by Clostridium difficile Is Regulated through Quorum Signaling
Darkoh, C., DuPont, H. L., Norris, S. J., & Kaplan, H. B. (2015) · mBio · doi:10.1128/mbio.02569-14 · Cited by 113
Epidemiological Model forClostridium difficileTransmission in Healthcare Settings
Lanzas, C., Dubberke, E. R., Lu, Z., Reske, K. A., & Grohn, Y. T. (2011) · Infection Control and Hospital Epidemiology · doi:10.1086/660013 · Cited by 111
Clostridium difficile in children: Colonisation and disease
Enoch, D., Butler, M. J., Pai, S., Aliyu, S. H., & Karas, J. A. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.05.016 · Cited by 108
Genisyuerek, S., Papatheodorou, P., Guttenberg, G., Schubert, R., Benz, R., & Aktories, K. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07549.x · Cited by 108
Development and application of MLVA methods as a tool for inter-laboratory surveillance
Nadon, C. A., Trees, E., Ng, L. ‐., Nielsen, E. M., Reimer, A. R., Maxwell, N., Kubota, K. A., Gerner‐Smidt, P., & Collective MLVA working group (2013) · Eurosurveillance · doi:10.2807/1560-7917.es2013.18.35.20565 · Cited by 105
Comparison of Strain Typing Results for Clostridium difficile Isolates from North America
Tenover, F. C., Åkerlund, T., Gerding, D. N., Goering, R. V., Boström, T., Jonsson, A.-M., Wong, E. Y., Wortman, A. T., & Persing, D. H. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02446-10 · Cited by 105
Piglet Models of Acute or ChronicClostridium difficileIllness
Steele, J., Feng, H., Parry, N. M., & Tzipori, S. R. (2009) · The Journal of Infectious Diseases · doi:10.1086/649799 · Cited by 102
Dobson, G., Hickey, C., & Trinder, J. (2003) · Intensive Care Medicine · doi:10.1007/s00134-003-1754-7 · Cited by 101
Hing, T. C., Ho, S., Shih, D. Q., Ichikawa, R., Cheng, M., Chen, J., Chen, X., Law, I. K. M., Najarían, R. M., Kelly, C. P., et al. (2012) · Gut · doi:10.1136/gutjnl-2012-302180 · Cited by 101
Crystal structure of Clostridium difficile toxin A
Chumbler, N. M., Rutherford, S. A., Zhang, Z., Farrow, M. A., Lisher, J. P., Farquhar, E. R., Giedroc, D. P., Spiller, B. W., Melnyk, R. A., & Lacy, D. B. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2015.2 · Cited by 99
Self-citationMartin, C. E., Broecker, F., Oberli, M. A., Komor, J., Mattner, J., Anish, C., & Seeberger, P. H. (2013) · Journal of the American Chemical Society · doi:10.1021/ja401410y · Cited by 98
Biofilm formation by Clostridium difficile
Đapa, T., & Unnikrishnan, M. (2013) · Gut Microbes · doi:10.4161/gmic.25862 · Cited by 98
Roberts, A. P., Johanesen, P., Lyras, D., Mullany, P. P., & Rood, J. I. (2001) · Microbiology · doi:10.1099/00221287-147-5-1243 · Cited by 97
Self-citationSchorch, B., Song, S., van Diemen, F. R., Bock, H. H., May, P., Herz, J., Brummelkamp, T. R., Papatheodorou, P., & Aktories, K. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323790111 · Cited by 97
Leeds, J. A., Sachdeva, M., Mullin, S., Barnes, S. W., & Ruzin, A. V. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt302 · Cited by 97
Knetsch, C. W., Terveer, E. M., Lauber, C., et al. (2012) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2012.06.003 · Cited by 96
Colonization Versus Carriage of Clostridium difficile
Donskey, C. J., Kundrapu, S., & Deshpande, A. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2014.11.001 · Cited by 96
Karlsson, S., Dupuy, B., Mukherjee, K., Norin, E. L., BURMAN, L. G., & Åkerlund, T. (2003) · Infection and Immunity · doi:10.1128/iai.71.4.1784-1793.2003 · Cited by 94
The Economic Impact of Clostridium difficile Infection: A Systematic Review
Nanwa, N., Kendzerska, T., Krahn, M. D., Kwong, J. C., Daneman, N., Witteman, W., Mittmann, N., Cadarette, S. M., Rosella, L. C., & Sander, B. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.48 · Cited by 93
Host S-nitrosylation inhibits clostridial small molecule–activated glucosylating toxins
Savidge, T., Urvil, P., Oezguen, N., Ali, K., Choudhury, A., Acharya, V., Pinchuk, I., Torres, A. G., English, R. D., Wiktorowicz, J. E., et al. (2011) · Nature Medicine · doi:10.1038/nm.2405 · Cited by 92
Analysis of Bacterial Communities during Clostridium difficile Infection in the Mouse
Semenyuk, E. G., Poroyko, V. A., Johnston, P. F., Jones-Burrage, S. E., Knight, K. L., Gerding, D. N., & Driks, A. (2015) · Infection and Immunity · doi:10.1128/iai.00145-15 · Cited by 92
Sun, X., & Hirota, S. A. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.09.005 · Cited by 91
Prediction Tools for Unfavourable Outcomes in Clostridium difficile Infection: A Systematic Review
Chakra, C. N. A., Pépin, J., & Valiquette, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030258 · Cited by 88
Characterization of a Stable, Metronidazole-Resistant Clostridium difficile Clinical Isolate
Lynch, T., Chong, P. M., Zhang, J., Hizon, R., Du, T., Graham, M., Beniac, D. R., Booth, T. F., Kibsey, P., Miller, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053757 · Cited by 87
Small animal models for the study ofClostridium difficiledisease pathogenesis
Hutton, M. L., Mackin, K. E., Chakravorty, A., & Lyras, D. (2013) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12367 · Cited by 87
Self-citationAdherence of Clostridium difficile spores to Caco-2 cells in culture
Paredes‐Sabja, D., & Sarker, M. R. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.043687-0 · Cited by 87
How to eradicate Clostridium difficile from the environment
Barbut, F. (2015) · Journal of Hospital Infection · doi:10.1016/j.jhin.2014.12.007 · Cited by 86
Olling, A., Seehase, S., Minton, N. P., Tatge, H., Schröter, S., Kohlscheen, S., Pich, A., Just, I., & Gerhard, R. (2011) · Microbial Pathogenesis · doi:10.1016/j.micpath.2011.10.009 · Cited by 86
Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review
Gabriel, L. E. K., & Beriot‐Mathiot, A. (2014) · Journal of Hospital Infection · doi:10.1016/j.jhin.2014.04.011 · Cited by 86
Bauer, M. P., Hensgens, M. P. M., Miller, M. A., Gerding, D. N., Wilcox, M. H., Dale, A. P., Fawley, W. N., Kuijper, E. J., & Gorbach, S. L. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis340 · Cited by 86
Self-citationRisk Estimation for Recurrent Clostridium difficile Infection Based on Clinical Factors
D’Agostino, R. B., Collins, S. H., Pencina, K. M., Kean, Y., & Gorbach, S. L. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu107 · Cited by 85
Structural Determinants of Clostridium difficile Toxin A Glucosyltransferase Activity
Pruitt, R. N., Chumbler, N. M., Rutherford, S. A., Farrow, M. A., Friedman, D. B., Spiller, B., & Lacy, D. B. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.298414 · Cited by 85
Self-citationStrategies to PreventClostridium difficileInfections in Acute Care Hospitals: 2014 Update
Dubberke, E. R., Carling, P., Carrico, R., Donskey, C. J., Loo, V. G., McDonald, L. C., Maragakis, L. L., Sandora, T. J., Weber, D. J., Yokoe, D. S., et al. (2014) · Infection Control and Hospital Epidemiology · doi:10.1017/s0899823x00193857 · Cited by 85
Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model
Baines, S. D., O'Connor, R., Saxton, K., Freeman, J., & Wilcox, M. H. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn502 · Cited by 83
Self-citationSokol, H., Galperine, T., Kapel, N., Bourlioux, P., Seksik, P., Barbut, F., Scanzi, J., Chast, F., Batista, R., Joly, F., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.08.017 · Cited by 81
van Coppenraet, L. E. S. B., Boer, M. D.-D., Ruijs, G. J. H. M., van der Reijden, W. A., van der Zanden, A. G. M., Weel, J. F. L., & Schuurs, T. A. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.02.007 · Cited by 80
Ziakas, P. D., Zacharioudakis, I. M., Zervou, F. N., Grigoras, C. A., Pliakos, E. E., & Mylonakis, E. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117195 · Cited by 79
Small Molecule Inhibitors of Clostridium difficile Toxin B-Induced Cellular Damage
Tam, J., Beilhartz, G. L., Auger, A., Gupta, P., Therien, A. G., & Melnyk, R. A. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.12.010 · Cited by 78
Mackin, K. E., Carter, G. P., Howarth, P. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079666 · Cited by 78
Yoshino, Y., Kitazawa, T., Ikeda, M., Tatsuno, K., Yanagimoto, S., Okugawa, S., Yotsuyanagi, H., & Ota, Y. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.11.017 · Cited by 74
Ho, T. D., & Ellermeier, C. D. (2011) · Infection and Immunity · doi:10.1128/iai.00019-11 · Cited by 74
Rosenbusch, K. E., Bakker, D., Kuijper, E. J., & Smits, W. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048608 · Cited by 74
Self-citationSuárez, J. M., Edwards, A. N., & McBride, S. M. (2013) · Journal of Bacteriology · doi:10.1128/jb.00166-13 · Cited by 74
CbpA: a novel surface exposed adhesin ofClostridium difficiletargeting human collagen
Tulli, L., Marchi, S., Petracca, R., Shaw, H. A., Fairweather, N. F., Scarselli, M., Soriani, M., & Leuzzi, R. (2013) · Cellular Microbiology · doi:10.1111/cmi.12139 · Cited by 73
Denève-Larrazet, C., Deloménie, C., Barc, M. C., Collignon, A., & Janoir, C. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47676-0 · Cited by 73
Proteomic Analysis of a NAP1 Clostridium difficile Clinical Isolate Resistant to Metronidazole
Chong, P. M., Lynch, T., McCorrister, S. J., Kibsey, P., Miller, M., Gravel, D., Westmacott, G., Mulvey, M. R., & (CNISP), T. C. N. I. S. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0082622 · Cited by 72
Defining an allosteric circuit in the cysteine protease domain of Clostridium difficile toxins
Shen, A., Lupardus, P. J., Gersch, M., Puri, A. W., Albrow, V. E., García, K. C., & Bogyo, M. S. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1990 · Cited by 71
Clostridium difficile Spore-Macrophage Interactions: Spore Survival
Paredes‐Sabja, D., Cofré-Araneda, G., Brito-Silva, C., Pizarro‐Guajardo, M., & Sarker, M. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043635 · Cited by 71
ClosTron-Mediated Engineering of Clostridium
Kuehne, S. A., Heap, J. T., Cooksley, C. M., Cartman, S. T., & Minton, N. P. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-197-0_23 · Cited by 69
Varier, R. U., Biltaji, E., Smith, K. J., Roberts, M. S., Kyle Jensen, M., LaFleur, J., & Nelson, R. E. (2015) · Infection Control & Hospital Epidemiology · doi:10.1017/ice.2014.80 · Cited by 68
Olling, A., Goy, S., Hoffmann, F., Tatge, H., Just, I., & Gerhard, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017623 · Cited by 68
Eyre, D. W., Tracey, L. E., Elliott, B., Slimings, C., Huntington, P. G., Stuart, R. L., Korman, T. M., Kotsiou, G., McCann, R. L., Griffiths, D., et al. (2015) · Eurosurveillance · doi:10.2807/1560-7917.es2015.20.10.21059 · Cited by 68
Self-citationJohann, P., Shaw, H. A., Couchman, E. C., Dawson, L. F., Yu, L., Choudhary, J. S., Kaever, V., Wren, B. W., & Fairweather, N. F. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.665091 · Cited by 67
Cited by
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Gut Microbiota and Colonization Resistance against Bacterial Enteric Infection
Ducarmon, Q. R., Zwittink, R. D., Hornung, B. V. H., van Schaik, W., Young, V. B., & Kuijper, E. J. (2019) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00007-19 · Cited by 566
Self-citationClinical Application and Potential of Fecal Microbiota Transplantation
Ooijevaar, R. E., Terveer, E. M., Verspaget, H. W., Kuijper, E. J., & Keller, J. J. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-111717-122956 · Cited by 336
Self-citationGut reactions: how the blood-brain barrier connects the microbiome and the brain
Logsdon, A. F., Erickson, M. A., Rhea, E. M., Salameh, T. S., & Banks, W. A. (2018) · Experimental Biology and Medicine · doi:10.1177/1535370217743766 · Cited by 235
Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics
Kordus, S. L., Thomas, A. K., & Lacy, D. B. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00660-2 · Cited by 204
Self-citation
Metadata
- Authors
- Smits, W. K., Lyras, D., Lacy, D. B., Wilcox, M. H., & Kuijper, E. J.
- Venue
- Nature Reviews Disease Primers
- Published
- 2016-04-07
- Volume
- 2
- Issue
- 1
- Pages
- 16020-16020
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W2182683962
- Cited by
- 853
- References
- 251
- FWCI
- 10.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.